Business
SINTX Technologies Achieves Placement on the Russell Microcap Index
SALT LAKE CITY, UT, June 09, 2021 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”) (www.sintx.com), an original
About this update from Sintx Technologies, Inc.
[{"type":"text","content":"SALT LAKE CITY, UT, June 09, 2021 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”) (www.sintx.com), an original equipment manufacturer (OEM) of silicon nitride ceramic for medical and non-medical applications, announced today it has joined the Russell Microcap Index. SINTX became a member of the Russell Investments family of U.S. indexes upon its official reconstitution, made effective on June 4. The Russell Microcap Index is a valuable tool for examining trends in smaller companies known as micro-caps. The Index is completely reconstituted annually to ensure new and growing equities are reflected and companies continue to reflect appropriate capitalization and value characteristics. The Russel Microcap Indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. It is constructed to provide a comprehensive and unbiased barometer for the microcap segment trading on national exchanges. The index covers the smallest stocks in the Russell 2000 with market caps between $50 and $300 million. “Our inclusion in the Russell Microcap Index demonstrates SINTX’s continued financial progress and strong business strategy toward the development of silicon nitride applications for antipathogenic, biomedical, and advanced ceramic uses,” stated Dr. Sonny Bal, Chairman and CEO. “SINTX continues to innovate with customers to develop applications such as wound care and dressings, spinal and dental implants, consumer facemasks, and more.” For more information on the Russell Microcap Index and the Russell indexes reconstitution, visit ftserussell.com. About SINTX Technologies, Inc. SINTX Technologies is an OEM ceramics company that develops and commercializes silicon nitride for medical and non-medical applications. The core strength of SINTX Technologies is the manufacturing, research, and development of silicon nitride ceramics for external partners. The company presently manufactures silicon nitride powders and components in its FDA registered, ISO 9001:2015 certified, ISO 13485:2016 certified, and AS9100D certified manufacturing facility. For more information on SINTX Technologies or its silicon nitride material platform, please visit www.sintx.com. Forward-Looking Statements This press release contains forward-looking statement...